These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

78 related items for PubMed ID: 7212714

  • 21. Irreversible enzyme inhibitors. CV. Differential irreversible inhibition of vertebrate dihydrofolic reductases by derivatives of 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-phenyl-s-triazines substituted with a terminal sulfonyl fluoride.
    Baker BR, Lourens GJ.
    J Med Chem; 1967 Nov; 10(6):1113-22. PubMed ID: 6056040
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. General distance geometry three-dimensional receptor model for diverse dihydrofolate reductase inhibitors.
    Ghose AK, Crippen GM.
    J Med Chem; 1984 Jul; 27(7):901-14. PubMed ID: 6737433
    [Abstract] [Full Text] [Related]

  • 29. Synthesis, in vitro antitumor activity, dihydrofolate reductase inhibition, DNA intercalation and structure-activity relationship studies of 1,3,5-triazine analogues.
    Singla P, Luxami V, Paul K.
    Bioorg Med Chem Lett; 2016 Jan 15; 26(2):518-523. PubMed ID: 26670841
    [Abstract] [Full Text] [Related]

  • 30. Inhibition of a methotrexate-insensitive dihydrofolate reductase from L5178Y cells by substituted triazines and quinazolines.
    Dedhar S, Freisheim JH, Hynes JB, Goldie JH.
    Biochem Pharmacol; 1983 Mar 01; 32(5):922-4. PubMed ID: 6838639
    [Abstract] [Full Text] [Related]

  • 31. Correlation analysis. Its application to the structure-activity relationship of triazines inhibiting dihydrofolate reductase.
    Silipo C, Hansch C.
    J Am Chem Soc; 1975 Nov 12; 97(23):6849-61. PubMed ID: 1237510
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Inactivation by mouse serum of a tightly bound inhibitor of dihydrofolate reductase.
    Fölsch E, Bertino JR.
    Mol Pharmacol; 1970 Jan 12; 6(1):93-8. PubMed ID: 5535872
    [No Abstract] [Full Text] [Related]

  • 36. Kinetic studies of the reaction mechanism of dihydrofolate reductase.
    Blakley RL, Schrock M, Sommer K, Nixon PF.
    Ann N Y Acad Sci; 1971 Nov 30; 186():119-30. PubMed ID: 4399848
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Comparative biochemistry of dihydrofolate reductase.
    Burchall JJ.
    Ann N Y Acad Sci; 1971 Nov 30; 186():143-52. PubMed ID: 4943573
    [No Abstract] [Full Text] [Related]

  • 39. A DFT-based QSAR study on inhibition of human dihydrofolate reductase.
    Karabulut S, Sizochenko N, Orhan A, Leszczynski J.
    J Mol Graph Model; 2016 Nov 30; 70():23-29. PubMed ID: 27649548
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.